Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3038 |
|
| Actual shortage: | 231 (8%) | |
| Anticipated shortage: | 14 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2784 (92%) | |
Discontinuation Reports |
356 |
|
| To be discontinued: | 22 (6%) | |
| Discontinued: | 334 (94%) | |
| Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (12%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-VARENICLINE | 1MG | TABLET | Actual shortage | 2024-04-19 | 2024-05-17 | 225764 |
| APO-TAMOX TAB 20MG | 20MG | TABLET | Actual shortage | 2024-04-12 | 2024-05-17 | 224990 |
| APO-RIVASTIGMINE | 3MG | CAPSULE | Resolved | 2024-05-03 | 2024-05-17 | 227085 |
| APO-MELOXICAM | 1.5G | SUSPENSION | Actual shortage | 2024-02-02 | 2024-05-17 | 218379 |
| APO-GLICLAZIDE MR | 60MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2024-01-26 | 2024-05-17 | 217481 |
| APO-FLUVOXAMINE | 100MG | TABLET | Resolved | 2024-04-05 | 2024-05-17 | 224592 |
| APO-DOMPERIDONE | 10MG | TABLET | Resolved | 2024-05-03 | 2024-05-17 | 227076 |
| APO-CYCLOBENZAPRINE | 10MG | TABLET | Resolved | 2024-05-03 | 2024-05-17 | 227091 |
| APO-BISOPROLOL | 5MG | TABLET | Actual shortage | 2024-04-12 | 2024-05-17 | 225023 |
| APO-BACLOFEN | 20MG | TABLET | Actual shortage | 2024-03-15 | 2024-05-17 | 222455 |
| APO-BACLOFEN | 10MG | TABLET | Actual shortage | 2024-04-12 | 2024-05-17 | 225011 |
| APO-BACLOFEN | 10MG | TABLET | Actual shortage | 2024-03-08 | 2024-05-17 | 221696 |
| APO-ATORVASTATIN | 80MG | TABLET | Actual shortage | 2024-05-03 | 2024-05-17 | 227088 |
| APO-AMLODIPINE-ATORVASTATIN | 80MG 10MG | TABLET | Actual shortage | 2024-02-16 | 2024-05-17 | 219843 |
| APO-WARFARIN | 1MG | TABLET | Resolved | 2024-04-19 | 2024-05-15 | 225782 |
| APO-WARFARIN | 1MG | TABLET | Resolved | 2024-04-05 | 2024-05-15 | 224589 |
| APO-FINGOLIMOD | 0.5MG | CAPSULE | Actual shortage | 2024-01-19 | 2024-05-10 | 216744 |
| APO-TICAGRELOR | 90MG | TABLET | Actual shortage | 2024-04-12 | 2024-05-10 | 225026 |
| APO-TRIMEBUTINE | 100MG | TABLET | Resolved | 2024-04-19 | 2024-05-10 | 225767 |
| APO-OXCARBAZEPINE | 300MG | TABLET | Resolved | 2024-04-05 | 2024-05-10 | 224598 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-NAPROXEN | 250MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60666 |
| APO-METFORMIN | 850MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40796 |
| APO-MEMANTINE | 10MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60615 |
| APO-MYCOPHENOLATE | 250MG | CAPSULE | Discontinued | 2018-09-07 | 2018-09-15 | 60637 |
| APO-MEDROXY TABLETS | 2.5MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60609 |
| APO-MELOXICAM | 7.5MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60612 |
| APO-LITHIUM CARBONATE | 300MG | CAPSULE | Discontinued | 2018-09-07 | 2018-09-15 | 60588 |
| APO-LOSARTAN | 50MG | TABLET | Discontinued | 2018-09-10 | 2018-09-15 | 60987 |
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-09-07 | 2018-09-15 | 60548 | ||
| APO-LATANOPROST-TIMOP | Discontinued | 2018-09-07 | 2018-09-15 | 60572 | ||
| APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40769 |
| APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40766 |
| APO-GLICLAZIDE | 80MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60512 |
| APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60539 |
| APO-FENTANYL MATRIX | 25MCG | PATCH | Discontinued | 2018-09-07 | 2018-09-15 | 60489 |
| APO-FENTANYL MATRIX | Discontinued | 2018-09-07 | 2018-09-15 | 60494 | ||
| APO-FENTANYL MATRIX | 75MCG | PATCH | Discontinued | 2018-09-07 | 2018-09-15 | 60497 |
| APO-FAMOTIDINE TAB 40MG USP | Discontinued | 2018-09-07 | 2018-09-15 | 60480 | ||
| APO-DONEPEZIL | 10MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60447 |
| APO-ESCITALOPRAM | 20MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60471 |